/24-7PressRelease/ - MONROVIA, CA, June 20, 2008 - Genentech is emerging from an environment in which all clinical trials outside the US involved a development partner with an established international infrastructure. The company is moving to a blended model in which it will conduct some clinical trials without relying on partners to develop and market drugs. In addition, because most biologics are currently developed in US markets, US patient enrollment has become competitive. The new blended model and the challenge of American patient enrollment are driving the company to increase patient enrollment abroad to support its expanding product pipeline and improve speed to market. Hence, Genentech needed a strategy for an international clinical distribution network that would support patient enrollment outside the US. Genentech's objective was to create an international clinical distribution network that would allow all clinical activities for molecules to be undertaken globally. A cross-functional project team was assembled at the company to devise short-term and long-term strategies for creating such a network. Mr. Pasuale will highlight the challenges faced by many US Biotechnology companies in creating an international clinical distribution network to support their pipeline of products, provide different business and logistical models that Genentech evaluated in creating an international clinical distribution network, give details on how to develop a simple cost model for making decisions regarding Build versus Outsource, and present Genentech's hybrid approach to international clinical distribution that includes outsourcing and direct ship models.
The Global Clinical Trial Operations conference brings together leaders, directors, vice presidents, heads, managers, supervisors, and CROs from all over the world to collaborate and discuss the latest developments in clinical trial operations and logistics and covers clinical trials in emerging markets, first-in-man clinical trials, pediatric clinical trials, material storage, distribution, site selection, patient recruitment and retention, technology in clinical trials and case studies of running global clinical trials.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=127.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Mike Romanos, Vice President of Discovery Technologies at GlaxoSmithKline to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Sharath Hegde, Vice President at Theravance to Give Featured Presentation at GTCbio's Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
- Barry Eisenstein, SVP at Cubist Pharmaceuticals to Give Keynote Presentation at GTCbio's Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
- VP of Alliance Management & Portfolio Planning at Genentech to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- GTCBIO ANNOUNCES ITS ANNUAL CONFERENCE GLOBAL CLINICAL TRIAL OPERATIONS ON SEPTEMBER 25-26, 2008, SAN DIEGO, CA
- GTCBIO ANNOUNCES ITS BIOMARKER DISCOVERY EUROPE CONFERENCE ON OCTOBER 2-3, 2008 IN DUBLIN, IRELAND
- GTCBIO ANNOUNCES ITS 4th ANNUAL NEURODEGENERATIVE DISEASES DRUG DISCOVERY CONFERENCE ON OCTOBER 9-10, 2008 IN PHILADELPHIA, PA
- GTCBIO ANNOUNCES ITS INAUGURAL BUGS & DUGS CONFERENCE ON SEPTEMBER 22-23, 2008, SAN DIEGO, CA
